Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
KDMN

Kadmon

$2.16

-0.05 (-2.26%)

04:55
08/14/17
08/14
04:55
08/14/17
04:55
Conference/Events
Kadmon management to meet with JMP Securities »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

KDMN

Kadmon

$2.29

-0.04 (-1.72%)

10:37
08/10/17
08/10
10:37
08/10/17
10:37
Conference/Events
Kadmon management to meet with JMP Securities »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

KDMN

Kadmon

$2.20

-0.05 (-2.22%)

09:03
08/07/17
08/07
09:03
08/07/17
09:03
Hot Stocks
Kadmon says FDA grants orphan drug designation for tesevatinib »

Kadmon Holdings announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KDMN

Kadmon

$2.20

-0.05 (-2.22%)

07:17
08/07/17
08/07
07:17
08/07/17
07:17
Hot Stocks
Kadmon non-small cell lung cancer treatment granted FDA orphan designation »

Kadmon's tesevatinib…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KDMN

Kadmon

$2.20

-0.0501 (-2.23%)

16:06
08/04/17
08/04
16:06
08/04/17
16:06
Syndicate
Breaking Syndicate news story on Kadmon »

Kadmon files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KDMN

Kadmon

$2.20

-0.0501 (-2.23%)

16:05
08/04/17
08/04
16:05
08/04/17
16:05
Syndicate
Breaking Syndicate news story on Kadmon »

Kadmon files $150M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KDMN

Kadmon

$2.20

-0.05 (-2.22%)

16:05
08/04/17
08/04
16:05
08/04/17
16:05
Syndicate
Breaking Syndicate news story on Kadmon »

Kadmon files $150M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KDMN

Kadmon

$2.25

-0.08 (-3.43%)

16:29
08/03/17
08/03
16:29
08/03/17
16:29
Earnings
Kadmon reports Q2 EPS (44c), consensus (49c) »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KDMN

Kadmon

$2.32

-0.07 (-2.93%)

, ABBV

AbbVie

$70.45

0.07 (0.10%)

14:45
08/02/17
08/02
14:45
08/02/17
14:45
Recommendations
Kadmon, AbbVie, Johnson & Johnson analyst commentary at Piper Jaffray »

Imbruvica approval in…

KDMN

Kadmon

$2.32

-0.07 (-2.93%)

ABBV

AbbVie

$70.45

0.07 (0.10%)

JNJ

Johnson & Johnson

$131.84

-0.669 (-0.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

  • 09

    Aug

  • 26

    Aug

  • 28

    Aug

  • 22

    Sep

KDMN

Kadmon

$2.72

-0.21 (-7.17%)

04:55
07/26/17
07/26
04:55
07/26/17
04:55
Conference/Events
Kadmon management to meet with Jefferies »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.